Literature DB >> 7895459

Apolipoprotein D gene polymorphism: a new genetic marker for type 2 diabetic subjects in Nauru and south India.

W A Baker1, G A Hitman, K Hawrami, M I McCarthy, A Riikonen, E Tuomilehto-Wolf, A Nissinen, J Tuomilehto, V Mohan, M Viswanathan.   

Abstract

Type 2 diabetes is characterized by abnormalities in both glucose and lipoprotein metabolism and genes involved in lipid metabolism are legitimate candidates for involvement in Type 2 diabetes. We have previously reported an association in Nauruans between a Taq 1 polymorphism of the apolipoprotein D gene (apo D) and Type 2 diabetes. In this study these findings were investigated further in the Nauruan population as well as two other ethnic groups. In South Indian subjects, there was a significant difference in genotype distribution of apo D genotypes between diabetic subjects (n = 110) and controls (n = 88; p = 0.004) which was similar to that previously found in the Nauruan subjects. No such association was seen in elderly Finnish subjects (diabetic n = 69; impaired glucose tolerance n = 26 and normal glucose tolerance n = 31). Linkage between the apo D polymorphism and diabetes in 12 Nauruan families was only excluded under a highly penetrant dominant model and was unlikely under other single gene models. Since the beta cell glucose transporter gene (Glut 2) is found in a similar chromosomal location to apo D, South Indian subjects (diabetic n = 95 and controls n = 56) were typed at this locus. No association between diabetes and the Glut 2 Taq I polymorphism was found in the South Indian subjects. Furthermore, there was no evidence of linkage disequilibrium between the apo D and Glut 2 genes. In conclusion, apo D might act as a modifying gene for Type 2 diabetes in some ethnic groups.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7895459     DOI: 10.1111/j.1464-5491.1994.tb00252.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

Review 1.  Apolipoprotein D.

Authors:  Eric Rassart; Frederik Desmarais; Ouafa Najyb; Karl-F Bergeron; Catherine Mounier
Journal:  Gene       Date:  2020-06-15       Impact factor: 3.688

Review 2.  Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

3.  A genome scan for renal function among hypertensives: the HyperGEN study.

Authors:  A T DeWan; D K Arnett; L D Atwood; M A Province; C E Lewis; S C Hunt; J Eckfeldt
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

4.  A role of apolipoprotein D in triglyceride metabolism.

Authors:  German Perdomo; Dae Hyun Kim; Ting Zhang; Shen Qu; Elizabeth A Thomas; Frederico G S Toledo; Sandra Slusher; Yong Fan; David E Kelley; H Henry Dong
Journal:  J Lipid Res       Date:  2010-02-02       Impact factor: 5.922

5.  High ApoD protein level in the round ligament fat depot of severely obese women is associated with an improved inflammatory profile.

Authors:  Frederik Desmarais; Karl-F Bergeron; Michel Lacaille; Isabelle Lemieux; Jean Bergeron; Simon Biron; Eric Rassart; Denis R Joanisse; Pascale Mauriege; Catherine Mounier
Journal:  Endocrine       Date:  2018-06-04       Impact factor: 3.633

6.  Cholesterol-related gene variants are associated with diabetes in coronary artery disease patients.

Authors:  Aybike Sena Ozuynuk; Aycan Fahri Erkan; Berkay Ekici; Nihan Erginel-Unaltuna; Neslihan Coban
Journal:  Mol Biol Rep       Date:  2021-05-21       Impact factor: 2.316

7.  Studies of ApoD-/- and ApoD-/-ApoE-/- mice uncover the APOD significance for retinal metabolism, function, and status of chorioretinal blood vessels.

Authors:  Nicole El-Darzi; Natalia Mast; Alexey M Petrov; Tung Dao; Artem A Astafev; Aicha Saadane; Erin Prendergast; Emmy Schwarz; Ilya Bederman; Irina A Pikuleva
Journal:  Cell Mol Life Sci       Date:  2020-05-21       Impact factor: 9.261

Review 8.  Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging.

Authors:  German Perdomo; H Henry Dong
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

9.  Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: a pilot study.

Authors:  Andrea G Edlow; Neeta L Vora; Lisa Hui; Heather C Wick; Janet M Cowan; Diana W Bianchi
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

Review 10.  Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity.

Authors:  C Gragnoli; G M Reeves; J Reazer; T T Postolache
Journal:  Transl Psychiatry       Date:  2016-04-19       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.